|
[PMID]: | 29296159 |
[Au] Autor: | Ridpath AD; Scobie HM; Shibeshi ME; Yakubu A; Zulu F; Raza AA; Masresha B; Tohme R |
[Ad] Endereço: | Centers for Disease Control and Prevention, Global Immunization Division, Atlanta, GA, USA. |
[Ti] Título: | Progress towards achieving and maintaining maternal and neonatal tetanus elimination in the African region. |
[So] Source: | Pan Afr Med J;27(Suppl 3):24, 2017. | [Is] ISSN: | 1937-8688 |
[Cp] País de publicação: | Uganda |
[La] Idioma: | eng |
[Ab] Resumo: | Despite the availability of effective tetanus prevention strategies, as of 2016, Maternal and Neonatal Tetanus Elimination (MNTE) has not yet been achieved in 18 countries globally. In this paper, we review the status of MNTE in the World Health Organization African Region (AFR),and provide recommendations for achieving and maintaining MNTE in AFR. As of November 2016, 37 (79%) AFR countries have achieved MNTE, with 10 (21%) countries remaining. DTP3 coverage increased from 52% in 2000 to 76% in 2015. In 2015, coverage with at least 2 doses of tetanus containing vaccine (TT2+) and proportion of newborns protected at birth (PAB) were 69% and 77%, compared with 44% and 62% in 2000, respectively. Since 1999, over 79 million women of reproductive age (WRA) have been vaccinated with TT2+ through supplementary immunization activities (SIAs). Despite the progress, only 54% of births were attended by skilled birth attendants (SBAs), 5 (11%) countries provided the 3 WHO-recommended booster doses to both sexes, and about 5.5 million WRA still need to be reached with SIAs. Coverage disparities still exist between countries that have achieved MNTE and those that have not. In 2015, coverage with DTP3 and PAB were higher in MNTE countries compared with those yet to achieve MNTE: 84% vs. 68% and 86% vs. 69%, respectively. Challenges to achieving MNTE in the remaining AFR countries include weak health systems, competing priorities, insufficient funding, insecurity, and sub-optimal neonatal tetanus (NT) surveillance. To achieve and maintain MNTE in AFR, increasing SBAs and tetanus vaccination coverage, integrating tetanus vaccination with other opportunities (e.g., polio and measles campaigns, mother and child health days), and providing appropriately spaced booster doses are needed. Strengthening NT surveillance and conducting serosurveys would ensure appropriate targeting of MNTE activities and high-quality information for validating the achievement and maintenance of elimination. |
[Mh] Termos MeSH primário: |
Doenças do Recém-Nascido/prevenção & controle Toxoide Tetânico/administração & dosagem Tétano/prevenção & controle
|
[Mh] Termos MeSH secundário: |
África/epidemiologia Erradicação de Doenças Feminino Seres Humanos Esquemas de Imunização Recém-Nascido Masculino Gravidez Tétano/epidemiologia Vacinação/estatística & dados numéricos Cobertura Vacinal Organização Mundial da Saúde
|
[Pt] Tipo de publicação: | JOURNAL ARTICLE; REVIEW |
[Nm] Nome de substância:
| 0 (Tetanus Toxoid) |
[Em] Mês de entrada: | 1802 |
[Cu] Atualização por classe: | 180215 |
[Lr] Data última revisão:
| 180215 |
[Sb] Subgrupo de revista: | IM |
[Da] Data de entrada para processamento: | 180104 |
[St] Status: | MEDLINE |
[do] DOI: | 10.11604/pamj.supp.2017.27.3.11783 |
|
|
|